Mereo BioPharma Group plc (NASDAQ:MREO) went up by 4.27% from its latest closing price compared to the recent 1-year high of $4.71. The company’s stock price has collected -2.22% of loss in the last five trading sessions. Press Release reported on 10/01/21 that Mereo BioPharma and Ultragenyx Present Data from the Phase 2b ASTEROID Study of UX143 (setrusumab) in Osteogenesis Imperfecta (OI) at the American Society for Bone and Mineral Research (ASBMR) 2021 Annual Meeting
Is It Worth Investing in Mereo BioPharma Group plc (NASDAQ :MREO) Right Now?
Opinions of the stock are interesting as 1 analysts out of 1 who provided ratings for Mereo BioPharma Group plc declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $10.00. MREO currently public float of 58.77M and currently shorts hold a 12.80% ratio of that float. Today, the average trading volume of MREO was 1.01M shares.
MREO’s Market Performance
MREO stocks went down by -2.22% for the week, with a monthly drop of -16.98% and a quarterly performance of -21.99%, while its annual performance rate touched 2.80%. The volatility ratio for the week stands at 5.26% while the volatility levels for the past 30 days are set at 6.30% for Mereo BioPharma Group plc. The simple moving average for the period of the last 20 days is -9.28% for MREO stocks with a simple moving average of -30.17% for the last 200 days.
Analysts’ Opinion of MREO
Many brokerage firms have already submitted their reports for MREO stocks, with BTIG Research repeating the rating for MREO by listing it as a “Buy.” The predicted price for MREO in the upcoming period, according to BTIG Research is $10 based on the research report published on May 05th of the current year 2021.
Needham, on the other hand, stated in their research note that they expect to see MREO reach a price target of $10. The rating they have provided for MREO stocks is “Buy” according to the report published on April 05th, 2021.
MREO Trading at -12.87% from the 50-Day Moving Average
After a stumble in the market that brought MREO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.30% of loss for the given period.
Volatility was left at 6.30%, however, over the last 30 days, the volatility rate increased by 5.26%, as shares sank -13.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.67% lower at present.
During the last 5 trading sessions, MREO fell by -2.22%, which changed the moving average for the period of 200-days by -38.38% in comparison to the 20-day moving average, which settled at $2.41. In addition, Mereo BioPharma Group plc saw -38.55% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for MREO
The total capital return value is set at -96.00, while invested capital returns managed to touch -552.04.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.47.